Ultragenyx Pharmaceutical (RARE) null Earnings

6MayConfirmed
Q3 2018
Q4 2018
Q1 2019
May 19
-2.09
-1.75
-1.4
-1.06

Details

Expected EPS
-1.74
Actual EPS
-1.82
Surprise EPS
-0.08
Surprise Percent
+4.6%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.82 per share for .

0 Comments

Share your thoughts